about
Oncogenes strike a balance between cellular growth and homeostasisFrom scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancerPrinciples of translational control: an overviewTargeting translation initiation in breast cancerMitochondrial DNA from the eradicated European Plasmodium vivax and P. falciparum from 70-year-old slides from the Ebro Delta in SpainTunable allosteric library of caspase-3 identifies coupling between conserved water molecules and conformational selectionMolecular architecture of the 40S⋅eIF1⋅eIF3 translation initiation complexFragile X mental retardation protein: A paradigm for translational control by RNA-binding proteinsA novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformationTunable protein synthesis by transcript isoforms in human cellsIdentification of phenotype-relevant differentially expressed genes in breast cancer demonstrates enhanced quantile discretization protocol's utility in multi-platform microarray data integration.Haematopoietic stem cells require a highly regulated protein synthesis rate.Mutations in the NOT Genes or in the Translation Machinery Similarly Display Increased Resistance to Histidine StarvationInterferons, signal transduction pathways, and the central nervous system.Ribosomopathies: mechanisms of disease.Cellular differences in protein synthesis regulate tissue homeostasis.A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancerMNKs act as a regulatory switch for eIF4E1 and eIF4E3 driven mRNA translation in DLBCL.Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.The Stability of Ribosome Biogenesis Factor WBSCR22 Is Regulated by Interaction with TRMT112 via Ubiquitin-Proteasome PathwayBiological Relevance and Therapeutic Potential of the Hypusine Modification System.Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: Mechanisms and targets for therapyThe DHX33 RNA Helicase Promotes mRNA Translation Initiation.Transcriptional signature induced by a metastasis-promoting c-Src mutant in a human breast cell line.Reversible induction of translational isoforms of p53 in glucose deprivation.mTOR coordinates protein synthesis, mitochondrial activity and proliferation.Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML PatientsBouvardin is a Radiation Modulator with a Novel Mechanism of ActionFossil and genomic evidence constrains the timing of bison arrival in North America.Functional Dynamics within the Human Ribosome Regulate the Rate of Active Protein Synthesis.Expression and activity of eIF6 trigger malignant pleural mesothelioma growth in vivo.Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease.Genome-wide analysis of the specificity and mechanisms of replication infidelity driven by imbalanced dNTP pools.Functions of ribosomal proteins in assembly of eukaryotic ribosomes in vivo.Posttranscriptional methylation of transfer and ribosomal RNA in stress response pathways, cell differentiation, and cancerStarving for more: Nutrient sensing by LIN-28 in adult intestinal progenitor cells.Riches of phenotype computationally extracted from microbial colonies.Anticipatory activation of the unfolded protein response by epidermal growth factor is required for immediate early gene expression and cell proliferation.Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity
P2860
Q26798085-506A41E7-3BA5-4B8D-97A9-F72001F0F24DQ26822694-E6953FE0-5C3B-4D53-BB3F-1D5702E109BBQ26995200-E6F52EBE-E13F-49BE-BCE5-5BD7841C2C4DQ27027284-762934BA-A7E0-469F-9A1F-0540E371EB59Q27133880-E5FBAEF7-4B93-4C82-81BC-F9C46CD680DDQ27728138-AE916501-0131-4681-99EE-C2AD745EB06EQ27934341-EFA657AC-3540-4C37-88AD-9FA6DF3D5DD3Q28086823-D8EA4CFF-C949-4161-B718-68965E614911Q28510855-90F65DD5-8138-48F9-9E31-1DD47EF06719Q28603873-61FA1E03-6D9D-4D29-8042-5AB0D65B8E16Q31114458-C70A54F1-5437-44AF-B5D4-9BF0B6CDAD4FQ33588717-0E9F65C3-DCF1-49C7-A192-599F648C427DQ33710950-69C84760-1BC9-4F9D-BC1C-9279C537D62AQ33988186-420E9F2D-1494-4373-A1EF-BA61488D6910Q34454066-4475D2CB-590D-48D9-AFAD-542AB84A71F3Q34462292-42265938-68A4-406A-B248-9CDA82011D08Q34518559-A00A460C-C971-4507-8791-F6DE78C56A5FQ34545783-B9820AA0-0A73-4B60-BB08-1060C1E5823DQ34683996-9A338285-EE5E-40BA-AFEA-A64B00E44BE1Q35715954-79D3A613-F446-4635-A3F1-D94F1BB188CCQ35883784-3DEC6C60-FD91-4E6A-A490-F942122A10AFQ35912293-22D0F01E-1878-4493-8D55-E73A022ECADBQ35917446-520D3AE6-FB57-4AFA-97B6-36CD2490B111Q35937176-19EF07C4-34BE-48DF-8CC8-128AB4A25249Q36067769-5E3B5E3D-6823-4B70-9AD8-0C26163091D7Q36189549-AE43E5F0-8DE7-4682-BE0C-81EF256FBB20Q36254052-4D3B15DB-3315-4AA9-8064-0FA937D889A4Q36274938-2DAEF427-367D-40C8-9BD1-E66BF0B4E9ACQ36306871-11A8ADB2-B97B-4D25-96F1-8D956251D659Q36320528-755E4ABD-0CA1-489E-B51A-09014BECC57EQ36545784-028043BE-27F9-4822-BD9F-E3962C2E47D9Q36557053-E89939A5-ABDA-4511-A7DC-6B7D128745CAQ36608855-F96A21C4-740F-48EF-8F81-67885B06E6B8Q36627910-2BFBA2A7-1583-4ED0-B623-AC20C1A6C813Q36633632-95AAA2D4-8696-44D0-A7A0-78DC5A7161D5Q36722453-FEE02550-FAC7-4880-BA9D-D1AEA5D5E72BQ36887669-310CA624-751C-4162-964B-6B0C268C5300Q36931115-4239FA59-B5C0-4832-8637-3B16D8F41D55Q37033459-4A686CAE-86F5-4077-BAF5-814C920F0334Q37104055-711D1C11-3E0F-4ECC-9C3B-49E09781A4DB
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Translational control in cancer etiology.
@ast
Translational control in cancer etiology.
@en
type
label
Translational control in cancer etiology.
@ast
Translational control in cancer etiology.
@en
prefLabel
Translational control in cancer etiology.
@ast
Translational control in cancer etiology.
@en
P2860
P1476
Translational control in cancer etiology.
@en
P2093
Davide Ruggero
P2860
P356
10.1101/CSHPERSPECT.A012336
P577
2013-02-01T00:00:00Z